Precigen, Inc

Precigen (Nasdaq: PGEN) is a biopharmaceutical company specializing in the advancement of innovative precision medicines to address difficult-to-treat diseases with high unmet patient need. Precigen is dedicated to advancing scientific breakthroughs from proof-of-concept through commercialization. With a strong commitment to innovation, Precigen is developing a robust pipeline of differentiated therapies across its core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases.

MEDICAL INFORMATION Precigen provides medical and product information upon request. Please note that information provided is not a substitute for advice from a healthcare professional. Always consult your physician or another qualified healthcare provider with any questions about medical conditions.

For medical inquiries, or to report a potential adverse event or product quality complaint related to a Precigen product, please contact the Precigen Medical Information team:

Phone: 1‑855‑PGE‑NRRP (1‑855‑743‑6777) Email: medinfo@precigen.com

You are encouraged to report negative side effects of prescription drugs to the FDA. Reports may be submitted online at www.fda.gov/medwatch or by calling 1‑800‑FDA‑1088.

Please do not report adverse events or product complaints through social media channels.